integrins
Jan 11, 2019
Triple Negative Breast Cancer Responds to TINAGL Therapy
Breast cancer develops when breast tissue cells grow abnormally and multiply. In essence, the hormones-- estrogen and progesterone-- and excess levels of human epidermal growth factor receptor 2 (HER2) protein are the known drivers of breast cancer. By testing samples of breast cancer tissue for hormone receptors a...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
